Fact Source: Financial Supervisory Service DART
💡 Executive Summary
Hanwha Aerospace disclosed the additional listing of 4,267,200 common shares issued through a rights issue to existing shareholders, scheduled for listing on July 21, 2025, at an issue price of KRW 684,000 per share.
📊 [Key Disclosure Contents & Summary of Figures]
- Company Name: Hanwha Aerospace Co., Ltd. (Stock Code: 012450)
- Disclosure Type: Additional Listing (Paid-in Capital Increase via Rights Issue)
- Disclosure Date: 2025-07-16
[Additional Listing Details]
- Class & Number of Shares: Registered Common Shares 4,267,200 shares (23rd Issue)
- Issue Price per Share: KRW 684,000 (Par Value: KRW 5,000)
- Date of Issuance: July 10, 2025
- Listing Date: July 21, 2025
- Dividend Record Date: January 1, 2025 (Fiscal year-end: December 31)
- Method of Capital Increase: Paid-in Capital Increase (Rights Issue to Existing Shareholders)
- Stock Codes: ISIN KR7012450003 / Short Code A012450
[Mandatory Lock-Up Details]
- Subject Entity: Hanwha Aerospace Employee Stock Ownership Association
- Lock-up Shares: 688,305 shares
- Lock-up Period: July 21, 2025 ~ July 21, 2026 (1 year)
📝 Editor’s Comment (Key Follow-up Checkpoint)
📌 Verification of Additional Listing Schedule and Lock-Up Quantities
This filing announces the upcoming listing on July 21, 2025, of 4,267,200 newly issued common shares resulting from a rights issue. Of the newly listed shares, 688,305 shares allocated to the Employee Stock Ownership Association are subject to a mandatory 1-year lock-up period starting from the listing date. Monitoring the additional listed shares and lock-up parameters is essential to confirming changes in the total number of issued shares. Investors can confirm further details in upcoming periodic filings (Annual, Half-Year, or Quarterly Reports) under the total number of shares section.
📢 Disclaimer and Source Information
Source: This content was structured and regenerated based on official data submitted to the Financial Supervisory Service’s DART system.
Investment Risk Warning: This content is provided for informational and linguistic reference purposes only. Under no circumstances does it constitute financial advice or a recommendation to buy or sell specific stocks. All investment decisions and financial responsibilities rest entirely with the investor.
Contact: For compliance inquiries or copyright-related requests, please contact ksb220805@gmail.com.
